HMG-CoA reductase inhibitors (statins) are established drugs for the treatment of
hypercholesterolemia. Furthermore, they induce regression of vascular atherosclerosis as well as reduction of cardiovascular-related morbidity and death in patients with and without
coronary artery disease. This book deals with statins which have substantially altered the approach to therapy of atherosclerosis and
its sequelae. Emphasis is placed on the scientific background to the discoveries and the development of the therapy, including an overview of the current state of knowledge of the drugs. Clinical data are reviewed extensively. This book not only provides the reader with valuable information but also
Drug books software:
Acsm's Exercise Management for Persons With Chronic Diseases and Disabilities, Short Protocols in Pharmacology and Drug
Discovery, Key Questions
in Surgical Critical Care,
A pictorial history of medicine: A brief, nontechnical survey of the healing arts from Aesculapius to Ehrlich, retelling with the aid of select illustrations the lives and deeds of great physicians